ORPHA:2882
Sitosterolemia
Also known as: Sisterolemia · Phytosterolemia
Publications
6,134
Trials
10
Interventional, condition-specific
Researchers
1,105
Distinct authors in sample
Gene link
ABCG5, ABCG8
Definitive
Readiness
5/6
Stages with a signal
Clinical definition (Orphanet)
Sitosterolemia is a rare sterol storage disease characterized by the accumulation of phytosterols in the blood and tissues. Clinical manifestations include xanthomas, arthralgia and premature atherosclerosis. Hematological manifestations include hemolytic anemia with stomatocytosis and macrothrombocytopenia. The disease is caused by homozygous or compound heterozygous mutations in ABCG5 (2p21) and ABCG8 (2p21) genes.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0008863
- MeSH:C537345
- UMLS:C0342907
- NCIT:C125694
Additional Mondo synonyms (2)
phytosterolemia · sitosterolemia
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
5/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedPresent
Definitive — ABCG5, ABCG8
- LiteraturePresent
6,134 matched papers (3,815 in last 10 years) Source
- Phenotype characterisedPresent
40 HPO annotations (e.g. Hypercholesterolemia; Elevated circulating sitosterol concentration; Tendon xanthomatosis) Source
- Animal modelPresent
1 genotype model (Mus musculus) Source
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
10 matched on ClinicalTrials.gov
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (ABCG5, ABCG8).
GenCC classification: Definitive.
Phenotypes (Monarch / HPO)
40
Associated phenotypes · MONDO:0008863
- Hypercholesterolemia
- Elevated circulating sitosterol concentration
- Tendon xanthomatosis
- Reticulocytosis
- Increased circulating lactate dehydrogenase concentration
Showing 5 of 40 — open Monarch for the full list.
Animal models (Monarch / Alliance)
1
Model associations linked to this Mondo ID
- Abcg8tm1Elk/Abcg8tm1Elk [background:] involves: 129S6/SvEvTac * C57BL/6J·MGI:3514172·Mus musculus
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
3
Drugs / clinical candidates · MONDO_0008863
- EZETIMIBE·phase 3
- COLESEVELAM·unknown
- FISH OIL·unknown
CTD chemicals (MyDisease.info)
2 associated chemicals · 10 pathways. Therapeutic evidence is listed first when present — not a treatment recommendation.
- Ezetimibe · therapeutic
- Sitosterols · marker/mechanism
Pathways: ABC transporters; Fat digestion and absorption; Bile secretion; ABC transporters in lipid homeostasis; Metabolism; Trafficking of dietary sterols; Transmembrane transport of small molecules; ABC-family proteins mediated transport
Literature
Is anyone studying this?
6,134
6,134 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
6,134 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
3,815 in the last 10 years · low confidence
Phrase hits: 1,312 · MeSH hits: 0
Who's working on it?
1,105
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Tada H16 papers · 2026
Department of Cardiovascular and Internal Medicine, Kanazawa University School of Medicine, Ishikawa, Japan.
Papers in Europe PMC - 02Kawashiri MA9 papers · 2026
Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Japan.
Papers in Europe PMC - 03Takamura M8 papers · 2025
Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences.
Papers in Europe PMC - 04Chen Y6 papers · 2025
Department of Pediatrics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
Papers in Europe PMC - 05Alenbawi J5 papers · 2026
College of Health and Life Sciences, Hamad Bin Khalifa University (HBKU), Doha, Qatar.
Papers in Europe PMC - 06Kojima N5 papers · 2024
Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences.
Papers in Europe PMC - 07Dobashi K4 papers · 2026
Department of Pediatrics, School of Medicine, University of Yamanashi.
Papers in Europe PMC - 08Nemer G4 papers · 2026
Division of Genomics and Translational Biomedicine, College of Health and Life Sciences, Hamad Bin Khalifa University, P.O. Box 34110, Doha, Qatar. gnemer@hbku.edu.qa.
Papers in Europe PMC - 09Nomura A4 papers · 2025
Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences.
Papers in Europe PMC - 10Wang H4 papers · 2025
Department of Pediatric Cardiology, Heart Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
10
interventional trials for this specific condition
10 interventional trials matched this specific condition name; none in our sample are currently recruiting.
Data as of 11 September 2026 · last trial check 28 July 2026
10 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 92.5th percentile).
low confidence · 92.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
10 interventional trials matched after quoted-phrase search and title/condition post-filter.
No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.
Observational and natural-history studies
3 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
None of the matched observational studies is currently listed as recruiting.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Sitosterolemia — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Sitosterolemia" OR "Sisterolemia" OR "Phytosterolemia") OR ("ABCG5" OR "ABCG5 syndrome" OR "ABCG5-related" OR "ABCG8" OR "ABCG8 syndrome" OR "ABCG8-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Sitosterolemia" OR "Sisterolemia" OR "Phytosterolemia"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 10 interventional · 3 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is short or not clearly distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (6134) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity
Ingested 2026-07-26T21:32:08.626Z
